S9279 • 2025

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Michael Gianaris
Last action: 2026-06-02
Official status: Senate Floor Calendar
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

What This Bill Does

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2026-06-02 Senate
SUBSTITUTED BY A3283C
2026-05-21 Senate
ADVANCED TO THIRD READING
2026-05-20 Senate
2ND REPORT CAL.
2026-05-19 Senate
1ST REPORT CAL.1239
2026-03-13 Senate
AMEND AND RECOMMIT TO HEALTH
2026-03-13 Senate
PRINT NUMBER 9279A
2026-02-24 Senate
REFERRED TO HEALTH

Official Summary Text

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

Current Bill Text

Read the full stored bill text

S T A T E   O F   N E W   Y O R K
        ________________________________________________________________________

                                          9279

                                    I N  S E N A T E

                                    February 24, 2026
                                       ___________

        Introduced  by Sen. GIANARIS -- read twice and ordered printed, and when
          printed to be committed to the Committee on Health

        AN ACT to amend the public health law, in relation to the  operation  of
          gene synthesis providers and manufacturers of gene synthesis equipment

          THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
        BLY, DO ENACT AS FOLLOWS:

     1    Section 1. Short title. This act shall be known and may  be  cited  as
     2  the "bioterrorism prevention act".
     3    §  2. The public health law is amended by adding a new article 32-B to
     4  read as follows:
     5                                ARTICLE 32-B
     6                             GENE SYNTHESIS LABS
     7  SECTION 3230. OPERATION OF GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF
     8                  GENE SYNTHESIS EQUIPMENT.
     9    § 3230. OPERATION OF GENE SYNTHESIS  PROVIDERS  AND  MANUFACTURERS  OF
    10  GENE  SYNTHESIS EQUIPMENT.   ANY GENE SYNTHESIS PROVIDER OR MANUFACTURER
    11  OF LABORATORY EQUIPMENT INTENDED FOR USE BY A  GENE  SYNTHESIS  PROVIDER
    12  SHALL  OPERATE  IN  ACCORDANCE  WITH RULES AND REGULATIONS ISSUED BY THE
    13  DEPARTMENT. THE DEPARTMENT SHALL  UTILIZE  GENERALLY  ACCEPTED  INDUSTRY
    14  STANDARDS  AND TAKE INTO CONSIDERATION RECOMMENDATIONS AND PROTOCOLS SET
    15  BY THE INTERNATIONAL GENE  SYNTHESIS  CONSORTIUM  AND/OR  OTHER  SIMILAR
    16  NATIONALLY OR INTERNATIONALLY RECOGNIZED RELEVANT ORGANIZATIONS TO DRAFT
    17  SUCH  RULES  AND  REGULATIONS.  FOR  THE  PURPOSE OF THIS SECTION, "GENE
    18  SYNTHESIS PROVIDER" SHALL MEAN ANY ENTITY THAT SYNTHESIZES AND  DISTRIB-
    19  UTES SYNTHETIC NUCLEIC ACIDS TO A CUSTOMER OR TO A DISTRIBUTOR.
    20    § 3. This act shall take effect immediately.



         EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04229-05-6